Insufficient human clinical data Most research on AOD-9604 has been conducted in animals or short-term human trials, making it difficult to determine its full long-term effects
Lebers hereditary optic neuropathy: B12 supplementation can worsen the conditionconsult a specialist (MedlinePlus)
In those patients, addressing the underlying metabolic dysfunction first, through dietary intervention, GLP-1 therapy if indicated, or NAD+ support for cellular energy metabolism, is the clinical priority
Definitely feel a difference in my energy levels however I find I need to take more than twice a week
The skin may be stretched or pinched to facilitate easier insertion, depending on the site and muscle mass
Are you comfortable using a compound without FDA approval